News

Interview with Dr Sekimizu, CEO of Provigate, ‘Blood glucose sensors that integrate into daily life to prevent the onset and severity of diabetes’, was published in the July 2021 issue of JSTnews. (In Japanese)

Provigate was introduced in the special feature ‘Medical Tech Ventures’ in the Weekly Toyo Keizai. (In Japanese)

‘An interview with Provigate’s external director, Yasunori Kaneko, a pioneering Japanese venture capitalist (4)’ was published online in Nikkei Biotech. (In Japanese)

‘An interview with Provigate’s external director, Yasunori Kaneko, a pioneering Japanese venture capitalist (3)’ was published online in Nikkei Biotech. (In Japanese)

‘An interview with Provigate’s external director, Yasunori Kaneko, a pioneering Japanese venture capitalist (2)’ was published online in Nikkei Biotech. (In Japanese)

‘An interview with Provigate’s external director, Yasunori Kaneko, a pioneering Japanese venture capitalist (1)’ was published online in Nikkei Biotech. (In Japanese)

Nikkei Business published online an article on Provigate: ‘What is GA, a new indicator for blood glucose levels in diabetes care, focused on by a University of Tokyo venture’. (In Japanese)

An interview with Dr Sekimizu, CEO of Provigate, is featured on the University of Tokyo FoundX website. (In Japanese)